I. Colina-Moreno

Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study

N. Rioux-Leclercq, C. Sautès-Fridman, A. Desnoyer, 2022, Journal for ImmunoTherapy of Cancer.

NIVOREN GETUG-AFU 26 translational study: Association of PD-1, AXL, and PBRM-1 with outcomes in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) treated with nivolumab (N).

N. Rioux-Leclercq, C. Sautès-Fridman, N. Chaput, 2020 .